CASH FLOW FROM OPERATING ACTIVITIES: | |
Net income | 265.27M |
Adjustments to reconcile net income to net cash provided (used) by operating activities: | |
Depreciation | 165.67M |
Amortization of debt issuance costs | |
Amortization of deferred items | |
Provision for doubtful accounts | |
Provision for inventory obsolescence | |
Deferred income tax expense (benefit) | 1.63M |
Share-based compensation expense | 11.86M |
Other, net | |
Changes in assets and liabilities: | |
Decrease in accounts receivable | 176.61M |
Decrease in insurance receivable | |
Decrease (increase) in income tax receivable | 2.61M |
Increase in inventory | 12.39M |
Decrease in prepaid expenses | 7.5M |
Increase in deferred costs and other assets | |
Increase in accounts payable | -36.23M |
Increase in accrued liabilities | -16.3M |
Decrease in income tax payable | -5.61M |
Increase (decrease) in deferred credits and other liabilities | |
Net cash provided by operating activities | 625.01M |
CASH FLOW FROM INVESTING ACTIVITIES: | |
Capital expenditures | -223.73M |
Proceeds from insurance | |
Proceeds from sale of assets | 20.79M |
Net cash used by investing activities | -202.94M |
CASH FLOW FROM FINANCING ACTIVITIES: | |
Principal payments on debt | |
Proceeds from debt | |
Proceeds from exercise of stock options | |
Debt issuance costs paid | -451K |
Net cash provided and used by financing activities | -390.63M |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 31.44M |
CASH AND CASH EQUIVALENTS, at beginning of period | 113.98M |
CASH AND CASH EQUIVALENTS, at end of period | 145.43M |
Non-cash activities | |
Increase (decrease) in accounts payable and accrued liabilities related to capital expenditures |